The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic levels.

“We are talking about sex and drugs—two topics that people call taboo,” said Brigitte Quenum, UNAIDS Regional Team Lead for ...

In June, the CDC started recommending doxycycline as a morning-after pill, specifically for gay and bisexual men ... There ...

Data from a phase Ia clinical trial of an oral, long-acting integrase inhibitor (GS-1720) in development for HIV demonstrated ...

ViiV Healthcare chief medical officer Harmony Garges said: “We know taking fewer medicines is an important consideration for ...

Revolutionary new HIV drugs are being made available in 120 low-income countries, but many important populations are being left out. Sophie Cousins reports.

Despite a mission to become a dominant cancer drug player, Gilead Sciences has as of late been locked in on its ...

The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

Researchers in South Africa are currently testing a longer-acting version of the dapivirine vaginal ring, a device designed ...

Since the first reported case of HIV in the U.S. 43 years ago, ending HIV epidemic is possible with new medicine that may ensure long, healthy lives and prevention.